Clinicopathological characteristics of male breast cancer

Yonsei Medical Journal

Volumn 49, Issue 6, 2008, Pages 978-986

  Park, Seho ^a   Kim, Joo Hee ^a   Koo, Jaseung ^a   Park, Byeong Woo ^a   Lee, Kyong Sik ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Internal Medicine   (South Korea)

Author keywords

Male breast cancer

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; EDUCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; KOREA; LYMPH NODE METASTASIS; MALE; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION DOSE; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 58149471987     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.6.978     Document Type: Article

References (33)

1. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002;137:678-87.
2. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
3. The Korean Breast Cancer Society. Nationwide Korean breast cancer data of 2004 using breast cancer registration program [In Korean]. J Breast Cancer 2006;9:151-61.
4. Son BH, Kwak BS, Kim JK, Kim HJ, Hong SJ, Lee JS, et al. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 2006;141:155-60.
5. Cho J, Han W, Ko E, Lee JW, Jung SY, Kim EK, et al. The clinical and histopathological characteristics of male breast cancer patients [In Korean]. J Breast Cancer 2007;10:211-6.
6. Malani AK. Male breast cancer: a different disease than female breast cancer? South Med J 2007;100:197.
7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56: 106-30.
8. Contractor KB, Kaur K, Rodrigues GS, Kulkarni DM, Singhal H. Male breast cancer: is the scenario changing. World J Surg Oncol 2008;6:58.
9. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-49.
10. Carlsson G, Hafström L, Jönsson PE. Male breast cancer. Clin Oncol 1981;7:149-55.
11. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 2005;15:773-80.
12. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002;17:457-62.
13. Ioka A, Tsukuma H, Ajiki W, Oshima A. Survival of male breast cancer patients: a population-based study in Osaka, Japan. Jpn J Clin Oncol 2006;36:699-703.
14. Matsuno RK, Anderson WF, Yamamoto S, Tsukuma H, Pfeiffer RM, Kobayashi K, et al. Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev 2007;16: 1437-42.
15. Nahleh Z, Girnius S. Male breast cancer: a gender issue. Nat Clin Pract Oncol 2006;3:428-37.
16. Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11-21.
17. Chung HC, Koh EH, Roh JK, Min JS, Lee KS, Suh CO, et al. Male breast cancer-a 20-year review of 16 cases at Yonsei University. Yonsei Med J 1990;31:242-50.
18. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471-9.
19. Meguerditchian AN, Falardeau M, Martin G. Male breast carcinoma. Can J Surg 2002;45:296-302.
20. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998;83:498-509.
21. Ko KH, Kim EK, Park BW. Invasive papillary carcinoma of the breast presenting as post-traumatic recurrent hemorrhagic cysts. Yonsei Med J 2006;47: 575-7.
22. Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992;135:734-48.
23. Volpe CM, Raffetto JD, Collure DW, Hoover EL, Doerr RJ. Unilateral male breast masses: cancer risk and their evaluation and management. Am Surg 1999;65:250-3.
24. Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, et al. Racial disparities in treatment and survival of male breast cancer. J Clin Oncol 2007;25: 1089-98.
25. Guénel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, et al. Alcohol drinking may increase risk of breast cancer in men: a European population-based casecontrol study. Cancer Causes Control 2004;15:571-80.
26. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:20-6.
27. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595-604.
28. Ribeiro GG, Swindell R, Harris M, Banerjee SS, Cramer A. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996;5:141-6.
29. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104: 2359-64.
30. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 year' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
31. Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 1997;173: 185-8.
32. The Korean Breast Cancer Society. Survival analysis of Korean breast cancer patients diagnosed between 1993 and 2002 in Korea-a nationwide study of the cancer registry [In Korean]. J Breast Cancer 2006;9:214-29.
33. Lee WS, Lee JE, Kim JH, Nam SJ, Yang JH. Analysis of prognostic factors and treatment modality changes in breast cancer: a single institution study in Korea. Yonsei Med J 2007;48:465-73.